Legend Biotech CAR T Therapies REMS Removed by FDA
Ticker: LEGN · Form: 6-K · Filed: Jun 30, 2025 · CIK: 1801198
| Field | Detail |
|---|---|
| Company | Legend Biotech Corp (LEGN) |
| Form Type | 6-K |
| Filed Date | Jun 30, 2025 |
| Risk Level | low |
| Sentiment | bullish |
Sentiment: bullish
Topics: regulatory-update, FDA, CAR-T
TL;DR
FDA REMOVES REMS FOR LEGEND BIOTECH CAR T THERAPIES, STREAMLINING ACCESS.
AI Summary
On June 26, 2025, Legend Biotech Corporation announced that the U.S. Food and Drug Administration (FDA) removed Risk Evaluation and Mitigation Strategies (REMS) for BCMA- and CD19-directed autologous CAR T cell immunotherapies. The product labeling has been updated to reflect this change and streamline patient monitoring.
Why It Matters
The removal of REMS simplifies the regulatory pathway for these CAR T cell therapies, potentially making them more accessible to patients and reducing administrative burdens for healthcare providers.
Risk Assessment
Risk Level: low — This is a positive regulatory update that removes a restriction, indicating a favorable development for the company's products.
Key Players & Entities
- Legend Biotech Corporation (company) — Registrant
- U.S. Food and Drug Administration (FDA) (company) — Regulatory body
- June 26, 2025 (date) — Date of FDA decision
- June 30, 2025 (date) — Report date
FAQ
What specific CAR T cell immunotherapies are affected by the REMS removal?
The REMS removal applies to currently approved BCMA- and CD19-directed autologous chimeric antigen receptor (CAR) T cell immunotherapies.
When did the FDA remove the REMS?
The FDA removed the REMS on June 26, 2025.
What changes were made to the product labeling?
Product labeling was updated to align with REMS elimination and streamline patient monitoring following product administration.
What is the filing date of this report?
This report was filed on June 30, 2025.
What is Legend Biotech Corporation's principal executive office address?
Legend Biotech Corporation's principal executive office is located at 2101 Cottontail Lane, Somerset, New Jersey 08873.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 30, 2025 regarding Legend Biotech Corp (LEGN).